The director of sleep health at Flinders University in Australia explored how combination pharmacologic and noninvasive therapies may offer a personalized path forward in obstructive sleep apnea treatment. [WATCH TIME: 6 minutes]
Danny Eckert, PhD
Advertisement
Articles by Danny Eckert, PhD
The director of sleep health at Flinders University explained how new mechanistic insights are enabling targeted pharmacotherapy and trait-based treatment for obstructive sleep apnea. [WATCH TIME: 3 minutes]
Proof-of-concept studies using a targeted phenotypic approach to reduce obstructive sleep apnea severity are showing exciting results.
The identification of 3 key non-anatomical contributors to OSA has unlocked new potential pharmacotherapies, a major advance for the field.
Advertisement
Latest Updated Articles
Danny Eckert, PhD: Unlocking New Targets For Pharmacological Therapy In OSAPublished: October 3rd 2018 | Updated:
- Danny Eckert, PhD: Pharmacotherapies Reducing OSA Severity
Published: October 4th 2018 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Alexander Gold, MD, on Adrabetadex’s Impact in Infantile-Onset Niemann-Pick C
2
NeurologyLive® Brain Games: November 2, 2025
3
Designing the Phase 3 EMPEROR Trial and Future Considerations
4
Showcasing Sustained Benefits in Myasthenia Gravis Research at AANEM 2025: Kimberly Moran, PhD, MBA
5
